SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-269284
Filing Date
2019-10-17
Accepted
2019-10-17 15:45:09
Documents
1
Group Members
BAY CITY CAPITAL FUND IV CO-INVESTMENT FUND, L.P.BAY CITY CAPITAL FUND IV, L.P.BAY CITY CAPITAL MANAGEMENT IV LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d819710dsc13da.htm SC 13D/A 93331
  Complete submission text file 0001193125-19-269284.txt   95199
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Subject) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82674 | Film No.: 191155110
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111 415.676.3830
BAY CITY CAPITAL LLC (Filed by) CIK: 0001288452 (see all company filings)

IRS No.: 943272448 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A